The week following ASCO 2021, we will host a series of live Q&A panels and discussion forums where leading physicians will filter data from the most clinically relevant and thought-provoking abstracts, consider how these results impact our current practice, and what questions they raise for further research.

What Changes Monday Morning Post ASCO Q&A | Updates in Breast Cancer - June 15, 2021
Dr. Kevin Kalinsky | Emory Winship Cancer Institute
Dr. Ann Partridge | Dana Farber Cancer Institute
Dr. Terry Mamounas | UF Orlando Health
Dr. Kristina Mirabeau-Beale | GenisisCare USA
Dr. Foluso Olabisi Ademuyiwa | Washington University

What Changes Monday Morning Post ASCO Q&A | Updates in Gastrointestinal Cancer - June 16, 2021
Dr. Louise Connell | Memorial Sloan Kettering
Dr. Cathy Eng | Vanderbilt-Ingram Cancer Center
Dr. Axel Grothey | West Clinic Cancer Institute
Dr. Shikha Jain | University of Illinois
Dr. Arturo Loaiza-Bonilla | Cancer Treatment Centers of America

What Changes Monday Morning Post ASCO Q&A | Updates in Lung Cancer - June 17, 2021
Dr. Hossein Borghaei | Fox Chase Cancer Center
Dr. Erin Gillaspie | Vanderbilt-Ingram Cancer Center
Dr. Shayma Kazmi | Cancer Treatment Centers of America
Dr. Kimberley Mak | Boston University Cancer Center
Dr. Ravi Salgia | City of Hope Cancer Center

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

​Amedco LLC designates this live activity for a maximum of. 1.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.